HCMA vs. NFYS, KVAC, GHIX, RCFA, SEDA, MCAA, HLXB, BRKH, CONX, and WNNR
Should you be buying HCM Acquisition stock or one of its competitors? The main competitors of HCM Acquisition include Enphys Acquisition (NFYS), Keen Vision Acquisition (KVAC), Gores Holdings IX (GHIX), RCF Acquisition (RCFA), SDCL EDGE Acquisition (SEDA), Mountain & Co. I Acquisition Corp. (MCAA), Helix Acquisition Corp. II (HLXB), Burtech Acquisition (BRKH), CONX (CONX), and Andretti Acquisition (WNNR). These companies are all part of the "holding & other investment offices" industry.
Enphys Acquisition (NYSE:NFYS) and HCM Acquisition (NASDAQ:HCMA) are both small-cap unclassified companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, community ranking, media sentiment and dividends.
In the previous week, HCM Acquisition had 1 more articles in the media than Enphys Acquisition. MarketBeat recorded 1 mentions for HCM Acquisition and 0 mentions for Enphys Acquisition. Enphys Acquisition's average media sentiment score of 0.59 beat HCM Acquisition's score of 0.00 indicating that HCM Acquisition is being referred to more favorably in the news media.
50.9% of Enphys Acquisition shares are owned by institutional investors. Comparatively, 11.8% of HCM Acquisition shares are owned by institutional investors. 27.4% of Enphys Acquisition shares are owned by company insiders. Comparatively, 71.2% of HCM Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Enphys Acquisition has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500. Comparatively, HCM Acquisition has a beta of -0.27, suggesting that its share price is 127% less volatile than the S&P 500.
Enphys Acquisition and HCM Acquisition both received 0 outperform votes by MarketBeat users.
Enphys Acquisition's return on equity of 0.00% beat HCM Acquisition's return on equity.
Summary
HCM Acquisition beats Enphys Acquisition on 4 of the 7 factors compared between the two stocks.
Get HCM Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCMA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HCMA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
HCM Acquisition Competitors List
Related Companies and Tools
